NDC11 51326092501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51326-0925-01 | 51326-0925 |
| 51326-0925-1 | 51326-0925 |
| 51326-925-01 | 51326-925 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Replenix Gly-Sal 2-2 | SALICYLIC ACID | Topiderm, Inc. | 6c6bbedc-e2ee-46a0-8800-e356bdd262b0 | 2024-07-25 | Warnings | 51326-925-01 51326-925 51326092501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.